Senolytic - Selectively induce death of senescent cells to improve humans’ health
Fouad Sabry
Casa editrice: One Billion Knowledgeable
Sinossi
What Is Senolytic There is a family of tiny compounds known as senolytics that are now the subject of fundamental study to establish whether or not they may selectively trigger cell death in senescent cells and enhance human health. This study aims to find or create treatments that may postpone the onset of age-related disorders, prevent them, relieve their symptoms, or even reverse their effects. The term "senostatic," which meaning to inhibit senescence, is one that is associated with this idea. How You Will Benefit (I) Insights, and validations about the following topics: Chapter 1: Senolytic Chapter 2: Life extension Chapter 3: Dasatinib Chapter 4: p16 Chapter 5: CGK733 fraud Chapter 6: Bcl-xL Chapter 7: Chromatin remodeling Chapter 8: Telomerase reverse transcriptase Chapter 9: ID1 Chapter 10: Cellular senescence Chapter 11: Fisetin Chapter 12: NKG2D Chapter 13: Human umbilical vein endothelial cell Chapter 14: Genetics of aging Chapter 15: Navitoclax Chapter 16: Senotherapy Chapter 17: ABT-737 Chapter 18: Senescence-associated secretory phenotype Chapter 19: Hallmarks of aging Chapter 20: Timeline of senescence research Chapter 21: Laura Niedernhofer (II) Answering the public top questions about senolytic. (III) Real world examples for the usage of senolytic in many fields. (IV) 17 appendices to explain, briefly, 266 emerging technologies in each industry to have 360-degree full understanding of senolytic' technologies. Who This Book Is For Professionals, undergraduate and graduate students, enthusiasts, hobbyists, and those who want to go beyond basic knowledge or information for any kind of senolytic.
